10.1093/cvr/cvad184 111
GLP-1 weight loss programs are medically guided treatments designed to support appetite control, improve satiety, regulate blood sugar balance, and assist with long-term weight management
Chromium is one of the more established nutrients for metabolic support research, though its effects at supplemental levels remain a subject of ongoing scientific discussion
While injectable GLP-1 medications demonstrate significant weight loss of 10-20% through FDA-approved formulations, patches have no substantial evidence supporting their effectiveness
doi: 10.1039/D3RA04070D 127
Before randomization, fasting blood glucose concentration was measured (EML 105 analyzer, Radiometer Medical A/S, Copenhagen, Denmark), and eligible individuals were randomized to receive two of three possible treatments (liraglutide 1.8 mg, 3.0 mg, or placebo)